microRNA (cel-miR-39) Spike-In Kit
A quantified synthetic RNA (cel-miR-39) for spike-in during RNA extraction procedures and subsequent normalization in RT-qPCR assays
For research use only and NOT intended for in vitro diagnostics.
microRNA (cel-miR-39) Spike-In Kit
A quantified synthetic RNA (cel-miR-39) for spike-in during RNA extraction procedures and subsequent normalization in RT-qPCR assays
Register today to receive an exclusive 15% off* on your first order.
Overview
- Well-accepted microRNA sequence used for normalization in gene expression studies
- Best suited for RNA purification from samples with low RNA abundance including liquid biopsies (plasma/serum/urine etc.) and low cell or tissue inputs
- Compatible to expression analysis using RT-qPCR - both RNA and matching forward PCR primer provided.
- Fully compatible to Norgen's microScript cDNA Synthesis system
- Fully compatible to Next Generation Sequencing (Small RNA-Seq) library preparation workflow
The amount of RNA that can be extracted from different biological or clinical samples varies greatly. For example, while a few micrograms of RNA could be easily purified from tissues and cells in excess amounts (such as from a few milligrams of tissue), many liquid biopsy samples may yield very low amounts of RNA. In fact, samples such as urine or plasma may yield 1 - 100 ng or less RNA per 100 µL of sample. Such a range of RNA quantity is often below the detection limit of most commonly used techniques for measuring RNA including nano-spectrophotometry and fluorescent nucleic acid stains. As a result, without properly determined RNA concentration, it becomes very difficult to normalize the starting quantity of RNA used in gene expression studies.
Norgen’s microRNA (cel-miR-39) Spike-In Kit offers a quantified synthetic RNA (cel-miR-39) for spike-in during RNA extraction procedures and subsequent normalization in RT-qPCR assays. The amount of cel-miR-39 RNA recovered after RNA extraction is directly correlated with the amount of total RNA recovered. After reverse transcription (such as with Norgen’s microScript Reverse Transcription system) of the sample RNA (with spike-in), the level of cel-miR-39 can be determined by subjecting the cDNA generated to quantitative PCR (qPCR) using fluorescent nucleic acid stains such as SYBR Green. A cel-miR-39 specific primer is included in the kit. The level of expression of any target transcripts in different RNA samples can now be normalized to the cel-miR-39 transcript level using standard method such as ∆∆Ct relative quantification.
In addition, the cel-miR-39 RNA is compatible to library preparation methods (including ligation-based protocols) in Next Generation Sequencing (Small RNA-Seq) workflows. The cel-miR-39 RNA could be used for normalization as well as for tracking library construction efficiency.
Details
Supporting Data
Storage Conditions
Upon receipt, store Norgen’s microRNA (cel-miR-39) Spike-In Kit at -20°C or lower. Avoid multiple freeze-thaw cycles. If needed, prepare smaller working aliquots and store at -20°C or lower.
Component | Cat. 59000 |
---|---|
cel-miR-39 RNA | 10 pmol |
cel-miR-39 Forward PCR Primer | 1 nmol |
Nuclease-Free Water | 1.25 mL |
Product Insert | 1 |
Documentation
Citations
Title | Investigation of a relationship between serum concentrations of microRNA-122 and alanine aminotransferase activity in hospitalised cats |
Journal | Journal of Feline Medicine and Surgery. 2022. |
Authors | Susan K Armstrong, Wilna Oosthuyzen and Richard J Mellanby |
Title | Carcinoma-associated fibroblasts release microRNA-331-3p containing extracellular vesicles to exacerbate the development of pancreatic cancer via the SCARA5-FAK axis |
Journal | Cancer Biology & Therapy. 2022. |
Authors | Yadong Han, Xu Qian, Teng Xu &Yang Shi |
Title | Moderate Endurance raining and MitoQ Improve Cardiovascular Function, Oxidative Stress, and Inflammation in Hypertensive Individuals: The Role of miR-21 and miR-222: A Randomized, Double- lind, Clinical Trial |
Journal | Cell Journal . 2022. |
Authors | Yaser Masoumi-Ardakani, M.Sc., Hamid Najafipour, Ph.D., Hamid Reza Nasri, M.D., Soheil Aminizadeh, Ph.D., Shirin Jafari, M.D., Zohreh Safi, B.Sc. |
Title | Evaluating the presence of deregulated tumoral onco-microRNAs in serum-derived exosomes of gastric cancer patients as noninvasive diagnostic biomarkers |
Journal | Bioimpacts. 2021. |
Authors | Houman Kahroba, Nasser Samadi, Mostafa Mostafazadeh, Mohamad Saied Hejazi, Mohammad Reza Sadeghi, Shahryar Hashemzadeh, Amir Taher Eftekhar Sadat, and Abbas Karimi |